Trevena
TRVNTrevena Inc is a clinical stage biopharmaceutical company, headquartered in Chesterbrook, Pennsylvania, USA, and is involved in the discovery and development of G-protein coupled receptors (GPCR) biased ligands. Trevena was founded in 2007 with technology licensed from Duke University, which origina …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2025
All insider trades at Trevena
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 6/28/2022 | Sell | Shin, Barry | SVP, CFO | $0.4 | $13,032 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)